|
TTC37 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.96579999950575E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.35990000038611E-07 |
| Normal-vs-Stage2 |
1.068440E-02 |
| Normal-vs-Stage3 |
2.442200E-02 |
| Normal-vs-Stage4 |
8.698000E-02 |
| Stage1-vs-Stage2 |
8.890400E-01 |
| Stage1-vs-Stage3 |
4.338200E-01 |
| Stage1-vs-Stage4 |
7.861800E-01 |
| Stage2-vs-Stage3 |
6.393800E-01 |
| Stage2-vs-Stage4 |
8.773800E-01 |
| Stage3-vs-Stage4 |
8.252000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.23669999691134E-08 |
| Normal-vs-AfricanAmerican |
3.798300E-04 |
| Normal-vs-Asian |
4.007600E-01 |
| Caucasian-vs-AfricanAmerican |
7.818200E-01 |
| Caucasian-vs-Asian |
6.475600E-01 |
| AfricanAmerican-vs-Asian |
7.450200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.33919986211595E-10 |
| Normal-vs-Female |
2.122600E-01 |
| Male-vs-Female |
7.639000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.836600E-03 |
| Normal-vs-Extreme_Weight |
1.38229983015492E-10 |
| Normal-vs-Obese |
1.019770E-03 |
| Normal-vs-Extreme_Obese |
2.945800E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.658200E-01 |
| Normal_Weight-vs-Obese |
6.930000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.562400E-01 |
| Extreme_Weight-vs-Obese |
2.184300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.133600E-01 |
| Obese-vs-Extreme_Obese |
4.462000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.405100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.104800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.41069997297672E-09 |
| Normal-vs-Age(81-100Yrs) |
1.70194999999929E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.112800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.101600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.014000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.448370E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.668020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.104800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.9755997665859E-10 |
| Normal-VS-Type2 PRCC |
1.745830E-02 |
| Normal-VS-KIRP CIMP |
1.238980E-04 |
| Normal-VS-Unclassified PRCC |
1.641040E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.374200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.508800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.169800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.521610E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.495600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.334980E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.89820000000052E-05 |
| Normal-vs-N1 |
2.306300E-02 |
| Normal-vs-N2 |
8.219100E-03 |
| N0-vs-N1 |
3.245400E-01 |
| N0-vs-N2 |
8.685200E-01 |
| N1-vs-N2 |
4.860600E-01 |
|
|
